The Lekhim Group of Companies plans to supply the first 500,000 doses of the Chinese vaccine against coronavirus (COVID-19) CoronaVac produced by Sinovac and purchased by the British agency Crown Agents at the expense of the national budget.
The company told Interfax-Ukraine on Thursday, the first delivery under this contract is expected on July 5.
In addition, the company said that on July 29, Lekhim carried out the last delivery of this vaccine under a contract with state-owned enterprise Medical Procurement of Ukraine.
As reported, Lekhim supplied 1.9 million doses of CoronaVac vaccine to Ukraine under a contract with the Health Ministry.
The contract with Crown Agents provides for the delivery of 7.7 million doses of this vaccine to the country.
The Chinese pharmaceutical company Sinovac will supply another 5.325 million doses of Coronavac vaccine against COVID-19 to Ukraine, said chief sanitary doctor of Ukraine Ihor Kuzin.
“Today we have signed commitments on Sinovac and it is planned that another 5.325 million doses of vaccine will be purchased by Crown Agents,” he said on Wednesday during an online discussion entitled “Why Ukrainians don’t want to be vaccinated.”
Kuzin said additional supplies of Coronavac vaccine are expected in July.
“We expect that all these volumes should come to Ukraine during July,” he said.
UNICEF will deliver 473,850 doses of Pfizer BioNTech vaccine to Ukraine by the end of next week as part of the COVAX initiative.
According to a UNICEF press release, the first 117,000 doses of this shipment arrived in Ukraine on Tuesday.
Earlier, within the framework of COVAX, 590,850 doses of Pfizer-BioNTech vaccine and 1.0728 million doses of AstraZeneca vaccine were delivered to Ukraine.
The COVAX Initiative aims to ensure fair and equitable access to COVID-19 vaccines for every country in the world. Ukraine receives all vaccines within the framework of COVAX free of charge.
On behalf of COVAX, UNICEF purchases and supplies only those COVID-19 vaccines that meet WHO’s safety and efficacy criteria.
COVAX is coordinated by the Global Alliance for Vaccines and Immunization (GAVI), WHO and the Coalition for Epidemic Preparedness Innovation (CEPI). UNICEF works with manufacturers and procurement and logistics partners for COVID-19 vaccines.
Within the framework of COVAX, by the end of 2021, Ukraine should receive enough vaccines from various manufacturers to protect up to 20% of the population from COVID.
On May 31, the Ministry of Health of Ukraine registered a European-made AstraZeneca vaccine against COVID-19 for emergency medical use, according to the agency’s website.
The vaccine, developed by Oxford University and the British-Swedish company AstraZeneca, is reportedly manufactured in Italy and has the trade name AstraZeneca. The AstraZeneca emergency vaccine has already been approved by the World Health Organization and has also been approved by the UK, EU, India and Canada.
By the end of the week, within the framework of the global COVAX initiative, 705,600 doses of the AstraZeneca vaccine will arrive in Ukraine. It will be intended for vaccination with a second dose of those who have already passed the 12-week interval after the first vaccination, in particular, doctors and healthcare workers, JFO participants, social workers, clergymen, employees of the Ministry of Internal Affairs, the Security Service of Ukraine, persons aged 65+. Also, the second dose of the vaccine is guaranteed to people who were vaccinated with residual doses or public figures.
As of Saturday morning, 123,964 Ukrainians received the second dose of the COVID-19 vaccine, the Ministry of Health of Ukraine said.
“As of today, 1.1 million Ukrainians received the first dose of the vaccine, 123,964 were vaccinated with two doses. A total of 1.1 million vaccinations were carried out,” the Ministry said on its Facebook page.
The British purchasing agency Crown Agents delivered the first 117,000 doses out of 167,000 doses of the Pfizer-BioNTech vaccine against COVID-19 to Ukraine from Belgium on Wednesday.
Crown Agents told Interfax-Ukraine that the second batch of vaccine (50,000 doses) is expected on Thursday.
According to head of Crown Agents in Ukraine Tetiana Korotchenko, the Pfizer-BioNTech vaccine was transported in compliance with all storage rules under the required temperature conditions.
In February, Crown Agents delivered 500,000 doses of Covishield vaccine to Ukraine, developed by AstraZeneca in cooperation with the University of Oxford.